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Inactivation by allelic exchange in clinical isolates of the emerging nosocomial pathogen Enterococcus
faecium has been hindered by lack of efficient tools, and, in this study, transformation of clinical isolates was
found to be particularly problematic. For this reason, a vector for allelic replacement (pTEX5500ts) was
constructed that includes (i) the pWV01-based gram-positive repAts replication region, which is known to
confer a high degree of temperature intolerance, (ii) Escherichia coli oriR from pUC18, (iii) two extended
multiple-cloning sites located upstream and downstream of one of the marker genes for efficient cloning of
flanking regions for double-crossover mutagenesis, (iv) transcriptional terminator sites to terminate undesired
readthrough, and (v) a synthetic extended promoter region containing the cat gene for allelic exchange and a
high-level gentamicin resistance gene, aph(2)-Id, to distinguish double-crossover recombination, both of
which are functional in gram-positive and gram-negative backgrounds. To demonstrate the functionality of this
vector, the vector was used to construct an acm (encoding an adhesin to collagen from E. faecium) deletion
mutant of a poorly transformable multidrug-resistant E. faecium endocarditis isolate, TX0082. The acm-deleted
strain, TX6051 (TX0082acm), was shown to lack Acm on its surface, which resulted in the abolishment of the
collagen adherence phenotype observed in TX0082. A mobilizable derivative (pTEX5501ts) that contains oriT
of Tn916 to facilitate conjugative transfer from the transformable E. faecalis strain JH2Sm::Tn916 to E. faecium
was also constructed. Using this vector, the acm gene of a nonelectroporable E. faecium wound isolate was
successfully interrupted. Thus, pTEX5500ts and its mobilizable derivative demonstrated their roles as impor-
tant tools by helping to create the first reported allelic replacement in E. faecium; the constructed this acm
deletion mutant will be useful for assessing the role of acm in E. faecium pathogenesis using animal models.
In today’s world, enterococci, especially some strains of En-
terococcus faecium, are best known in the clinical setting as
multidrug-resistant opportunists causing difficult-to-treat hos-
pital-acquired infections, including infective endocarditis (32,
33). While in the past clinical isolates of Enterococcus faecalis
outnumbered those of E. faecium by approximately 9:1, this
ratio has changed in some U.S. hospitals to 6:4, and this
increase parallels the increase in vancomycin resistance of E.
faecium (20, 33, 58). An important theme relating to strains
causing E. faecium infections in hospitals today is that, in
addition to acquiring antibiotic resistances, they seem to have
lost the harmless, commensal nature of the strains colonizing
healthy individuals in the community and often contain either
new genes (e.g., espfm, encoding a potential enterococcal sur-
face protein, or hyl, encoding a potential hyaluronidase [16, 25,
44, 62]) or a functional form of genes (e.g., acm, encoding a
collagen adhesin [37]), thus presumably enhancing their ability
to survive and/or cause infection in the clinical setting. While
espfm and hyl genes were found to be rare in isolates from
healthy volunteers and in isolates from animal origin (44), the
acm gene was present in these isolates as an inactive gene (37
and S. R. Nallapareddy and B. E. Murray, unpublished re-
sults). To study virulence traits of E. faecium, it is necessary to
have appropriate genetic methods. However, tools for con-
structing targeted mutations in E. faecium are rudimentary or
contain resistant genes frequently present in clinical isolates.
Several methods have been previously developed for tar-
geted mutagenesis of enterococci and found to be useful for
genetic manipulation of E. faecalis. One of these makes use of
plasmids that are suicidal in gram-positive hosts (13, 15, 43,
51). A second method of allelic replacement, involving elec-
troporation of E. faecalis with DNA from a pool of mini--
mutagenized cosmid clones, is applicable for genes with de-
tectable phenotypes (28, 51). The disadvantage of these two
techniques is the requirement for efficient transformation,
since selection depends on both successful bacterial transfor-
mation and successful integration in the same step. However,
the problem with enterococci is that, although some strains are
readily transformable using electroporation, others are not. A
third method of delivery integration is based on pORI19/
pGhost3 and requires individual transformation with two dif-
ferent plasmids (45). Other methods based on conjugation
systems (30, 56) and temperature-sensitive (ts) plasmids (1, 12,
47) have also been used intermittently for E. faecalis mutagen-
esis to circumvent the difficulty of electroporation. However,
these vectors were constructed for specialized uses and lack
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many characteristics associated with cloning vectors, such as
availability of unique recognition sites and appropriate mark-
ers that would be useful in mutagenesis of clinical isolates of E.
faecium. Additionally, the ts-based plasmids used in mutagen-
esis of other gram-positive bacteria usually contain remnants
of enterococcal transposons Tn916 and Tn917, thus posing
potential problems with recombination into these elements
which are common in clinical isolates.
In spite of a number of available vector systems, due to low
transformability of the host as well as some limitation in each
of the vector system(s) described above, we and others have
had limited success in generating targeted mutations in E.
faecium genes. The two E. faecium genes that were interrupted,
albeit with low efficiency, in our laboratory were generated in
the moderately transformable E. faecium strain TX1330 (also
known as SE-34), a fecal isolate, isolated from a healthy com-
munity volunteer (50, 55). It is important to note that this E.
faecium fecal strain does not contain espfm or hyl, nor does it
express acm (the acm gene of this strain is a pseudogene), the
three potential virulence-related genes described to date for
this species (37, 44).
In order to circumvent the limitations described above, in
the present study we engineered Escherichia coli-enterococcal
cloning vectors that are conditionally suicidal in enterococci at
nonpermissive growth temperatures and which harbor antibi-
otic genes that are selectable in both Escherichia coli and
enterococci. Appropriate acm gene fragments were cloned into
these new vectors and then used to introduce allelic replace-
ment or disruption mutations in the acm gene of clinical strains
of E. faecium.
MATERIALS AND METHODS
Bacterial strains, plasmids, and growth conditions. E. coli, E. faecalis, and E.
faecium strains used in this study are listed in Table 1. Enterococcal isolates
initially identified to the species level by biochemical tests were confirmed by
colony hybridization (49) using an intragenic ace probe for E. faecalis (9, 36) and
an aac(6)-Ii probe for E. faecium (9). E. coli strains were grown in Luria-Bertani
media (Difco Laboratories, Detroit, Mich.). Enterococci were grown in either
TABLE 1. Bacterial strains and plasmids used in this study
Strain or plasmid Relevant characteristic(s)a Reference or source
Strains
E. faecium
TX1330 Fecal isolate from community volunteer; Amps, Chls, Erys, Gens, Kanr, Strs, Tets; Cn-Adh 8, 37
TX2466 Blood isolate; Eryi, Kanr, Gens, Vanr This study
TX0082 Endocarditis isolate; Ampr, Chls, Eryr, Kanr, Gens, Vanr; Cn-Adh This study
TX2555 Perineal wound isolate; Chls, Eryr, Kanr, Gens, Vanr; Cn-Adh 37
TX6051 TX0082acm, acm deletion mutant of TX0082, Chlr; Cn-Adh This study
TX6054 TX2555acm::pTEX6052, acm insertion disruption mutant of TX2555, Genr, Cn-Adh This study
E. faecalis
JH2Sm::Tn916 JH2 harboring Tn916; Gens, Strr, Tetr 6
TX6053 JH2Sm::Tn916(pTEX6052); Strr, Tetr, Genr This study
OG1RF Laboratory strain; Rifr, Fusr, Chls, Gens 35
E. casseliflavus
UC73 aph(2)-Id containing strain; Genr 59
E. coli
DH5	 E. coli host strain for routine cloning Stratagene
TX5500 DH5	(pTEX5500ts); Chlr, Genr This study
TX5501 DH5	(pTEX5501ts); Chlr, Genr This study
TX6050 DH5	(pTEX6050); Chlr, Genr This study
TX6052 DH5	(pTEX6052); Genr This study
Plasmids
pAM401 Shuttle plasmid; Chlr and, in E. coli, Tetr 64
pAT18 Shuttle plasmid; Eryr 60
pTV1-OK pWV01 replicon-based ts vector; Kanr, Eryr 14
pTV1-ts pE194 replicon-based ts vector; Chlr, Eryr 66
pAM401ts pIP501 replicon-based ts vector; Chlr 60
pFW14 Streptococcal integration vector; Chlr 42
pHS1 E. faecalis mobilizable ts plasmid containing oriTTn916; Kan
r, Genr 1
pTEX5500ts Shuttle plasmid, ts in gram-positive hosts; Chlr, Genr This study
pTEX5501ts Mobilizable ts vector containing oriTTn916; Chl
r, Genr This study
pTEX6050 Plasmid for acm deletion with flanking regions of the acm binding domain cloned into
pTEX5500ts; Chlr, Genr
This study
pTEX6052 acm insertion construct, intragenic fragment of acm cloned into pTEX5501ts with deletion
of cat; Genr, Chls
This study
a Chl, chloramphenicol; Ery, erythromycin; Fus, fusidic acid; Gen, gentamicin; Kan, kanamycin; Rif, rifampin; Tet, tetracycline; Str, streptomycin; Van, vancomycin;
and ts, temperature sensitive. Superscript “s” designates sensitivity, “r” designates resistance, and “i” designates intermediate susceptibility (MIC of 2 to 4 
g/ml for
Ery); for aminoglycosides “r” is defined for enterococci as MIC  500 for Gen and  2,000 for Kan. Cn-Adh, adherence to collagen types I and IV; Cn-Adh, no
adherence to collagen types I and IV.
VOL. 72, 2006 GENETIC TECHNIQUES FOR E. FAECIUM 335
brain heart infusion (BHI) or Todd-Hewitt (TH) broth or agar (Difco Labora-
tories) at 37°C, unless a different growth temperature is specified. The following
antibiotic concentrations were used with enterococci: chloramphenicol, 10 
g/
ml; erythromycin, 15 
g/ml (for selection of transformants); erythromycin, 200

g/ml [for selection of naturally resistant E. faecium strains due to msrC (50) plus
erm(B)]; gentamicin, 125 
g/ml; and tetracycline, 10 
g/ml. With E. coli, the
concentrations used were chloramphenicol, 10 
g/ml; erythromycin, 200 
g/ml;
and gentamicin, 25 
g/ml. All antibiotics were obtained from Sigma Chemical
Co. (St. Louis, Mo.). All plasmids used in this study are listed in Table 1. All
constructs were given TX numbers as shown in Table 1. Plasmids from these
constructs were assigned respective pTEX numbers.
Standard molecular techniques. Specific primers were purchased either from
Invitrogen (Carlsbad, Calif.) or from Sigma-Genosys (The Woodlands, Tex.).
Restriction enzymes and DNA modification enzymes were purchased mostly
from Invitrogen, and reactions were carried out under the recommended con-
ditions. Bovine collagen type I was purchased from Cohesion Technologies, Inc.
(Palo Alto, Calif.), collagen type IV was purchased from Sigma Chemical Co.,
and fibrinogen was purchased from Enzyme Research Laboratories (South
Bend, Ind.). Tran35S label and bovine serum albumin (BSA) were purchased
from MP Biomedicals Inc. (Irvine, Calif.). All other chemicals used in the
investigation were of molecular biology grade. Chromosomal DNA from E.
faecium isolates was prepared following the hexadecyltrimethyl ammonium bro-
mide method described earlier (63). Plasmid DNA isolation from E. coli used the
Wizard Plus SV minipreps DNA purification system (Promega Corporation,
Madison, Wis.) and, from enterococci, by a previously described method (65).
General recombinant DNA techniques such as ligation and agarose gel electro-
phoresis were performed using standard methods (46). When necessary, DNA
fragments were purified with low-melting-point agarose gels followed by purifi-
cation using QIAquick-gel extraction kits (QIAGEN, Inc., Valencia, Calif.).
PCRs were performed with a Perkin-Elmer GeneAmp PCR system 9700 using
the optimized buffer B (1 buffer: 60 mM Tris-HCl [pH 8.5], 15 mM ammonium
sulfate, and 2 mM MgCl2) obtained from Invitrogen. PCR-generated fragments
were purified using the Wizard PCR DNA Cleanup System (Promega Corpora-
tion). Recombinant plasmids were generated in E. coli DH5	. Agarose plugs
containing genomic DNA were digested with SmaI, and pulsed-field gel electro-
phoresis (PFGE) was performed using previously described methods (34) but
with different ramped pulse times, 2 s and 28 s. Southern blotting was performed
using Hybond-N nylon membranes and a 0.4 N NaOH solution. The RadPrime
DNA Labeling System (Invitrogen) was used to label the probes with
[	-32P]dCTP (GE Healthcare, Piscataway, NJ), and hybridizations were carried
out using high-stringency conditions (35). DNA sequencing reactions were per-
formed by the Taq dye-deoxy terminator method and an automated ABI Prism
sequencer (Applied Biosystems, Foster City, Calif.). Sequences were assembled
using SeqMan program of DNASTAR software (Lasergene; Madison, Wis.).
Bacterial electrotransformation and conjugation. Electroporation of E. coli,
E. faecalis, and E. faecium was carried out using a Gene Pulser (Bio-Rad Lab-
oratories, Richmond, Calif.) as described previously (28, 50). Broth-mating ex-
periments were performed as previously described (57), except for a donor:
recipient ratio of 2:1. In brief, overnight cultures of 0.5 ml of donor and 0.25 ml
of recipient were added to 4.25 ml of fresh BHI broth, and the mixture was
incubated without shaking at 28°C overnight. After vortexing, cells were har-
vested by centrifugation at 4,000 rpm and 4°C and resuspended in 200 
l of saline
followed by plating on BHI agar plates with 200 
g/ml erythromycin and 125

g/ml gentamicin. Plates were checked for colonies for up to 96 h (at 24-h
intervals) of incubation at 28°C. For some strains, in an effort to increase the
conjugation frequency, filter-mating experiments were also performed as previ-
ously described (57), except for a donor/recipient ratio of 20:1. In brief, 1 ml of
an overnight culture of donor (grown at 28°C in BHI broth containing 125 
g/ml
gentamicin and 10 
g/ml tetracycline to increase the transfer frequency [6]) and
50 
l of an erythromycin-resistant recipient were added to 4.5 ml of fresh BHI
broth, and the mixture was then passed through a 0.45-
m membrane filter
(Millipore, Bedford, Mass.). The cells trapped on the filters were incubated at
28°C overnight and were then suspended in 1 ml of saline. Appropriate dilutions
of the mixture were transferred to BHI agar plates containing 200 
g/ml eryth-
romycin and 125 
g/ml gentamicin. Plates were assessed for colonies after 24 and
48 h of incubation at 28°C.
Determination of plasmid segregation rates. TX0082 transformed with
pTEX5500ts (construction of this plasmid is described in Results and Discussion)
was grown at 28°C with 10 
g of chloramphenicol and 125 
g of gentamicin per
ml until the optical density at 600 nm (OD600) reached approximately 1. The
culture was then diluted 1:1,000 with fresh BHI broth and grown overnight (16
h) without antibiotic selection at 28, 37, and 42°C. Initial and final numbers of
TX0082 cells with and without pTEX5500ts were determined by quantitative
plate counting on agar plates with and without antibiotics after growth at 28°C.
Plasmid segregation rates were derived from these CFU using the following
formula described by Framson et al. (11): percent loss per generation  [1 
(Ff/Fi)1/g]  100, where F is the frequency of the plasmid-mediated resistance
phenotype in the population, f is the final CFU, i is the initial CFU, and g is the
number of generations intervening between the final and initial CFU (deter-
mined on nonselective media) according to the formula g  [loge (final CFU/
initial CFU)]/loge (2).
Growth curves. Overnight cultures were inoculated in BHI broth at a dilution
of 1:100. The cultures were then grown at 37°C with shaking in an orbital shaker,
and the aliquots were removed hourly from 0 to 12 h and at 24 h for determining
CFU on BHI agar and also to measure the absorbance at 600 nm (OD600) with
a spectrophotometer.
Cell wall-associated protein extraction and Western blotting. Protein extracts
from E. faecium strains were prepared using mutanolysin (Sigma Chemical Co.)
as described previously (37). Protein concentrations were estimated by bicincho-
ninic acid assay (Pierce, Rockford, Ill.). Equal concentrations of mutanolysin
extracts were electrophoresed in 4 to 12% NuPAGE Bis-Tris gels (Invitrogen)
under reducing conditions in morpholinepropanesulfonic acid buffer and were
transferred to a polyvinylidene difluoride membrane according to the protocol
supplied by Invitrogen. Membranes were then probed with anti-AcmA poly-
clonal antiserum or preimmune serum (antibody I) (37) followed by Protein A
horseradish peroxidase conjugate (antibody II) and developed with 4-chlo-
ronaphthol in the presence of H2O2.
Adherence assay. Adherence of E. faecium to collagen, fibrinogen, and BSA
was determined in four independent experiments using Tran35S-labeled bacteria
by a previously described assay (37).
Nucleotide sequence accession numbers. Nucleotide sequences of
pTEX5500ts and pTEX5501ts were submitted to GenBank under accession
numbers DQ208936 and DQ208937.
RESULTS AND DISCUSSION
The recent increase in multidrug-resistant E. faecium infec-
tions and its emergence as a nosocomial pathogen highlight the
need for genetic studies addressing the mechanism of bacterial
pathogenesis of this species. Although we and others have
reported the presence of homologues of known virulence fac-
tors among E. faecium strains (e.g., efaAfm, espfm, hyl, and acm)
(25, 37, 44, 49, 62), the relative contributions of these genes to
E. faecium pathogenicity have not been assessed, largely due to
the lack of tools for replacement of a wild-type gene with a
mutated gene. Our repeated attempts to generate targeted
mutations in some E. faecium clinical strains with suicide, tem-
perature-sensitive, and/or mobilizable vector systems (1, 51,
56) developed for E. faecalis mutagenesis were unsuccessful.
Hence, the aims of this study were to develop a delivery and
screening system of E. faecium and to validate the applicability
of this system for generating targeted mutations in the acm
gene of E. faecium clinical isolates. As a first step, some clinical
strains were screened for their ability to acquire plasmid
pAM401.
Clinical strains of E. faecium are poorly transformable. We
and others previously found that E. coli-E. faecalis shuttle
plasmids (e.g., pAM401, pWM401, and pAT18) can be trans-
formed into and will replicate in selected strains of E. faecium,
although they do so with some instability in the absence of
selection pressure. However, the three E. faecium strains that
we previously reported as transformable (37) either lack the
virulence factors of interest (44) or contain a pseudogene (37).
In this study, diverse E. faecium strains containing potential
virulence genes were screened for their transformation capa-
bility using electroporation conditions optimized for E. fae-
cium (50) and a pIP501-derived high-copy-number shuttle
plasmid, pAM401 (64). Results from this preliminary experi-
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ment using a total of 11 human-derived E. faecium strains,
including 8 clinical isolates, revealed that strains varied mark-
edly in their ability to acquire this plasmid, with most failing to
do so (Table 2). As is evident from Table 2, among the tested
strains, the community-derived fecal E. faecium isolate
TX1330 exhibited high transformation efficiency, in the range
of 1,200 to 4,000 CFU/
g of plasmid. Similar transformation
efficiencies were noted for pAT18 (with the pAM1 replicon)
with this strain. Two other strains that were found to be mod-
erately transformable were D344-S (a laboratory recipient iso-
late and spontaneous mutant of D344 [48]) and an American
Type Culture Collection (ATCC 51558) recipient isolate, GE-1
(10). Their efficiencies of transformation were 100-fold less
than that of pAM401 transformation into E. faecalis OG1X
(64). While some clinical strains exhibited low-level transfor-
mation with pAM401 (e.g., an endocarditis isolate TX0082
yielded 33  8 CFU/
g of plasmid), others appeared to be
nontransformable (e.g., wound isolate TX2555) (Table 2). Ad-
ditionally, in the absence of selective pressure, ca. 6 to 16% of
overnight cultures were found to have lost pAM401 in three
independent experiments. Poor transformability increases the
difficulty of using suicidal vectors and motivated us to explore
conditional replicons that may be applicable for E. faecium.
Transformation and stability of conditional replication
based ts plasmids in E. faecium. At least two thermosensitive
broad-host-range vector families (derived from pWVO1 and
pE194) have been shown to be useful for high-efficiency gene
inactivation and replacement in gram-positive bacteria (2, 3, 5,
17, 41, 54). In order to test the applicability of these systems in
E. faecium, the ability of three established ts plasmids,
pTV1-OK (14), pTV1-ts (66), and pAM401ts (60), derived
from pWV01, pE194, and pIP501 replicons, respectively, were
assessed to transform and replicate in the transformable E.
faecium strain, TX1330, at permissive temperature (estab-
lished as 30°C for other gram-positive bacteria). All three plas-
mids were found to transform, although poorly, and replicate
in TX1330 at 28°C (Table 3). At 30°C, recovery of transfor-
mants was found to be reduced to approximately half of what
we recovered at 28°C. Among these three ts plasmids,
pTV1-OK showed maximum recovery, followed by pAM401ts,
and pTV1-ts being the least (Table 3). Restriction digestions of
plasmids analyzed from transformants grown at 28°C identified
that pTV1-OK and pTV1-ts were relatively stable in E. faecium
at permissive temperature and maintained their original mo-
lecular sizes. In contrast, pAM401ts in E. faecium was unstable
with multiple deletions and different colonies showed different
digestion patterns. Since pTV1-OK is not suitable for E. fae-
cium clinical strains (due to lack of appropriate markers and
the presence of Tn917), we selected pHS1 (a pWV01ts-based
E. faecalis suicidal vector [1]) and introduced it in two clinical
strains (TX0082 and TX2466) at 28°C. We next cloned an acm
intragenic fragment into pHS1 and introduced this plasmid
into E. faecium TX0082 by electroporation, selected at 28°C,
with subsequent growth of an individual colony at 42°C. In
addition to the expected single-crossover recombination into
acm at the nonpermissive temperature (42°C), persistence of
the plasmid was noticed in TX0082 even after 10 serial pas-
sages at 42°C. Upon sequencing, we found that RepA of this
construct was not that of the more ts version found in pVE6004
(29) but rather is like the parental plasmid pWV01 (27), which
is able to replicate at higher temperatures. This observation
warranted the need for a vector that would be more reliably
nonreplicative at elevated temperatures.
Construction of pTEX5500ts and its mobilizable derivative.
Since currently available vectors often contain regions of DNA
from enterococci as markers, which may lead to undesired
recombination, the minimal functional regions were amplified
using specific primers containing rare restriction sites. The
streptococcal integration vector pFW14, containing two mul-
tiple-cloning sites (MCS), was used as the backbone for
pTEX5500ts construction (Fig. 1). The vector pFW14 is a
derivative of pFW8 (42) in which the aad9 promoter driving cat
gene expression has been replaced by a synthetic promoter
region from pFW11 (42) that contains two extended 10 and
35 boxes. To clone a minimal gram-positive ts replicon re-
gion by restriction digestion and ligation (and also to add
commonly used restriction sites to MCS-II of pFW14), we first
introduced ClaI, PvuI, EcoRI, KpnI, EcoRV, and SstII restric-
tion sites into the MCS-II. This was done by treating the
appropriately designed synthetic primer duplexes with T4
TABLE 2. Transformation efficiencies of various strains of
E. faecium with high-copy-number shuttle vector pAM401
Strain (reference) Source No. oftransformants/
ga
TX1330 (8, 37) Fecal isolate from
community volunteer
2,113  1,313
D344-S (37, 48) Laboratory recipient 955  503
GE-1 (10) Recipient (ATCC 51558) 222  86
TX0054 (37) Endocarditis 0
TX0082 (this study) Endocarditis 33  8
TX2535 (37) Endocarditis 0
TX2699 (this study) Endocarditis 0b
TX2095c (this study) Catheter tip 0b
TX2092 (this study) Rectum 9  3
TX2084 (this study) Urine 0
TX2555 (37) Wound 0
a All experiments were carried out with 500 ng of pAM401 DNA isolated from
E. coli DH5	. Electroporation was performed with a Bio-Rad Gene Pulser
apparatus with the following conditions: 12.5 kV (per 1-cm cuvette), 25 mF
capacitance, and 400  resistance. These values represent the means and stan-
dard deviations of three independent competent cell preparations.
b Sporadically, some breakthrough colonies were found on chloramphenicol
plates. These colonies did not contain pAM401 and, upon restreaking, were
unable to grow on chloramphenicol plates.
TABLE 3. Transformation efficiencies of E. faecium TX1330 with
various plasmids
Plasmid
(replicon, type)a
Size
(kb)
Antibiotic
markerb
No. of
transformantsc/
g
pAM401 (pIP501, ) 10.4 Chl 2,113  1,313
pTV1-OK (pWV01, RC) 11 Ery 64  6
pTV1-ts (pE194, RC) 12.4 Chl 13  3
pAM401ts (pIP501, )d 10.4 Chl 19  2
a The replicon is derived from the replication apparatus of the original plas-
mid. The replication mechanism used by the plasmid is RC, rolling circle, or ,
theta.
b Antibiotic markers used to select for the plasmid transformants. Ery, eryth-
romycin; Chl, chloramphenicol.
c These values represent the means and standard deviations of three indepen-
dent competent cell preparations.
d This plasmid is highly unstable in E. faecium.
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DNA polymerase and T4 polynucleotide kinase (52) and sub-
sequent cloning into the SmaI site of pFW14. This intermedi-
ate construct was designated pFW14M (Fig. 1). The gentami-
cin resistance gene aph(2)-Id was then amplified from
Enterococcus casseliflavus strain UC73 (59) using primers
GentF and GentR (Table 4). This PCR-amplified fragment
containing the aph(2)-Id gene and its promoter and termina-
tor regions was digested with SstII and then ligated to similarly
FIG. 1. Construction of pTEX5500ts, a temperature-sensitive (ts) delivery vector, and its mobilizable derivative, pTEX5501ts. Both vectors
contain a ts version of the broad-host-range pWV01 replicon for replication in gram-positive hosts at permissive temperatures and oriR derived
from pUC18 to replicate in E. coli. Arrow directions in each plasmid indicate the direction of transcription. Only relevant restriction sites are
shown. Maps of pTV1-OK and pHS1, not shown here, have been previously published (1, 14). MCS, multiple cloning sites; cat, the chloramphenicol
acetyltransferase gene from pC194; tt, transcriptional terminator sites (tts from pFW14 are not shown in pFW14M and pFW14Mgent constructs);
E. coli oriR, origin of replication derived from pUC18; aph(2)-Id, gentamicin resistance gene from E. casseliflavus; gram-positive ts replicon,
temperature-sensitive origin of replication from pTV1-OK; IR, inverted repeats; oriTTn916, origin of transfer region of Tn916; and Mob
,
mobilizable by trans-activation from strains harboring Tn916.
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digested pFW14M, and this construct was designated
pFW14MGent (Fig. 1). The gentamicin resistance gene of this
vector functions as a spacer as well. We next ligated the ts
replicon (obtained by filling in the eluted 2.5-kb XbaI frag-
ment of pTV1-OK with T4 DNA polymerase, followed by
treating with T4 polynucleotide kinase and finally digesting
with KpnI) and the previously KpnI- and EcoRV-digested
pFW14MGent. This construct was designated pTEX5500ts
(Fig. 1). To construct plasmid pTEX5501ts, the PCR-amplified
oriT fragment (using primers oriTF and oriTR) from the E.
faecalis mobilizable vector pHS1 (1) was digested with SpeI
and MluI and then ligated into similarly digested pTEX5500ts
(Fig. 1).
With the aim of improving the selection efficiency of these
vectors, we sought to utilize a counter selection based on su-
crose sensitivity, proven to be functional in some other gram-
positive bacteria (4, 21, 39, 40). Cloning of sacB derived from
Bacillus subtilis (encoding levansucrase) under the extended
synthetic promoter of pFW14 followed by electroporation in E.
faecium strain TX1330 resulted in normal growth of the trans-
formant even in medium containing sucrose. At this stage, it is
unknown whether the sacB product is nonfunctional in E.
faecium or whether the toxicity due to the sacB product was
complemented by an alternate mechanism of sucrose resis-
tance. Similarly, with the aim of facilitating detection of allelic
exchange events, blue-white selection as a reporter system was
also investigated. However, growth of E. faecium on plates with
5-bromo-4-chloro-3-indolyl--D-galactopyranoside rendered a
light-blue colonial phenotype indistinguishable from colonies
containing the lacZ construct we made from pORI280 (26).
Additionally, use of a new marker encoded by emtA (31) was
also found to be ineffective due to the observed background
growth of avilamycin-susceptible E. faecium when electrocom-
petent cells (1  1010 CFU) were plated.
Properties of the newly derived ts replicon vector,
pTEX5500ts. pTEX5500ts contains (i) E. coli oriR of pUC18
derived from the streptococcal integration vector pFW14 (42);
(ii) a gram-positive repAts replicon from pTV1-OK (14) which
is functional in E. faecium at a permissive temperature; (iii)
two distinct multiple cloning sites (MCSs) on either side of the
cat gene to provide several alternative sites for cloning of
flanking regions for double-crossover mutagenesis; (iv) a syn-
thetic functional promoter region (with two extended 35 and
10 boxes) to overcome relatively low expression levels of the
pC194-based cat gene (19, 42, 61); (v) a gentamicin resistance
gene aph(2)-Id from E. casseliflavus (59); (vi) transcriptional
terminator sites (tts) to terminate undesired readthrough and
to prevent destabilizing effects of cloned inserts; and (vii)
primer sites flanking each of the MCSs (5500-MCS-IF, 5500-
MCS-IR, 5500-MCS-IIF, and 5500-MCS-IIR [Table 4]) that
facilitate screening the vector by PCR or for DNA sequencing
across the vector-insert junctions. The cat gene encoding chlor-
amphenicol resistance can be used as a marker for selecting
chromosomal integration. The gentamicin resistance marker
located on the vector can be used to distinguish double-cross-
over recombinants after plasmid excision. Both resistance
markers are functional in E. coli and enterococcal back-
grounds. Restriction sites adjacent to each of these markers
will be helpful for replacing them with alternative markers, as
needed. Although the tt positioned downstream of the cat gene
may have some disadvantages due to a possible polar effect, in
this study, it was found to be necessary for cloning of the
AcmDn fragment (see below) in MCS-II of pTEX5500ts. A
similar observation of the necessity of introduction of tts for
efficient cloning of streptococcal DNA fragments was reported
in previous studies (7). However, it is possible to use this vector
to generate a nonpolar mutation of polycistronic genes by
cloning the flanking regions contiguously in-frame followed by
deletion of the cat cassette including its terminator.
Upon complete sequencing of pTEX5500ts, an additional
SmaI site in the 5 region of the ts replicon and creation of an
EcoRI site due to a single mutation in MCS-II were noticed.
TABLE 4. Primers used in this study
Primer name Type Sequence (5 3 3)a
GentF Forward TTCCCCGCGGAGATAGGTTATGCAAGATTTTTATATG
GentR Reverse TTCCCCGCGGATTCCGGATTCTAAAAAAGGATTGCTA
5500-MCS-IFb Forward GACAATACTGATAAGATAATATATC
5500-MCS-IRb Reverse TTACGTTACGTTATTAGTTATAG
5500-MCS-IIFb Forward TTTGTTTTATTATTTAATATTTGG
5500-MCS-IIRb Reverse GCCGATAACTAAACGAAATAAACG
oriTF Forward GGACTAGTTTTTATACTCCCCTTGTACCAAAAG
oriTR Reverse GGACGCGTCAAAGGACGAATATGTCGCCTAAAG
AcmDelF1 Forward CGCGGATCCTATCTCTTGAAACGTTCTTAGAATTGC
AcmDelR1 Reverse CCCAAGCTTACTATATCATCTCTCAAAAATCCTTTC
AcmDelF4 Forward AAAACTGCAGAATGAGAACCAAGACGGCAAACGAC
AcmDelR6 Reverse TCCCCCGGGCCAGCAGGTACAGTGACTCCATTAGC
AcmUp11 Forward TTTGTAAATAATTGGATGGCAGATT
CmR Reverse AAAGCATTTTCAGGTATAGGTG
CmF Forward GAATGACTTCAAAGAGTTTTATG
AcmDownR11 Reverse AACCGAACAAGAAGCTTATGAACTA
AcmF2 Forward CAGGCAGAGATATCAGCAG
AcmR1 Reverse ATTCTCATTTGTAACGACTAGC
AcmInsF Forward CGCGGATCCACGAATATTACAGATGGAGGAAACA
Acm19R Reverse CGGGGTACCTTAATTTTTAACTGTATGATTGAAACTTTC
a Introduced restriction sites are underlined.
b These primers flanking each of the MCS will facilitate DNA sequencing across the vector-insert junctions.
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Since these restriction sites are also part of MCS-II, these sites
still can be used in cloning procedures. However, XbaI of
MCS-I and NdeI and ClaI of MCS-II are unusable because of
their secondary occurrence in aph(2)-Id. These plasmids
should be high copy number in E. coli due to the pUC18-based
replicon, are stable after growth at 37°C, and should be low
copy number (the pGK12 parent of the pWV01 replicon is
known to occur in three copies per cell in lactococci [24]) in
gram-positive hosts at permissive temperatures.
Replication, temperature sensitivity, and segregation stabil-
ity of pTEX5500ts. To ensure replication, both postelectropo-
ration incubation and growth on selective media (48 to 96 h)
were performed at 28°C. When the primary selection plates
contained more than one antibiotic (i.e., both chloramphenicol
and gentamicin), either no transformants were found or they
were very rare. Using gentamicin for selection, transformation
with successful replication was tested with TX1330 and four
clinical isolates. Among these, TX1330 yielded more colonies,
as anticipated from the above results, in the range of transfor-
mation efficiencies noted with pTV1-OK (ca. 80 CFU/
g of
plasmid). Two clinical strains that we were able to transform
with pTEX5500ts are TX0082 and TX2466, albeit with poor
efficiency, i.e., 13 and 9 CFU/
g of plasmid, respectively. The
trend of these results is consistent with those obtained with
pAM401 (Table 2), suggesting that the transformation variabil-
ity is a property of the specific strain and not plasmid instabil-
ity. Colonies that appeared on selective plates were grown in
BHI broth with gentamicin, and plasmid DNA isolated from
overnight cultures was detected by agarose gel electrophoresis
(data not shown).
In E. faecium, pTEX5500ts was found to be relatively stable,
showing 48% retention (stability seen in three independent
experiments was 60, 35, and 49%) of the chloramphenicol
resistance phenotype following 16 h of growth at 28°C in the
absence of antibiotics. In order to confirm the permissive and
nonpermissive temperatures for the replication of pTEX5500ts
in E. faecium, the stability of this plasmid was analyzed at
different temperatures. The ratio of the number of CFU on
selective plates to the number of CFU on nonselective plates
dropped by ca. 3,100 and ca. 4,700-fold at 37 and 42°C, respec-
tively. The segregation rates of the chloramphenicol resistance
phenotype from TX0082 in broth culture in the absence of
antibiotic selection at different temperatures were as follows:
at 37°C, 59% per generation; at 42°C, 64% per generation; and
at 28°C, 5% per generation. These results confirm that
pTEX5500ts exhibits a dramatic loss in plasmid replication
between 28 and 37 or 42°C, as observed with pWV01ts-based
plasmids in other gram-positive pathogens. In subsequent ex-
periments, a culture temperature of 42°C completely cured the
plasmid from TX0082 after five serial passages. The nonper-
missive temperature of 42°C found for pTEX5500ts in E. fae-
cium does not limit the applicability of this system, since these
organisms are characterized by high heat tolerance and grow
relatively well up to 45°C.
Construction of a deletion mutation in the acm gene of the
collagen-binding E. faecium endocarditis isolate, TX0082. To
demonstrate the applicability of our new vector for targeted
gene disruption, the acm gene was chosen. The choice of acm
is because of our hypothesis that Acm plays a role in E. faecium
pathogenesis, including endocarditis (37). This is based on our
earlier observation of the predominance of a functional acm
gene in clinical isolates but a pseudogene in fecal and animal
isolates (37 and S. R. Nallapareddy and B. E. Murray, unpub-
lished results) and also data for the importance of the Staph-
ylococcus aureus collagen adhesin Cna (an Acm homologue) in
animal models, including endocarditis (18, 23, 38). Figure 2
outlines the protocol that was used for acm gene replacement
in E. faecium. A 1,106-bp DNA fragment designated AcmUp
(Fig. 2), encompassing the region upstream of acm, was am-
plified from TX0082 genomic DNA template using primers
AcmDelF1 and AcmDelR1 (Table 4), digested with BamHI
and HindIII and ligated with similarly digested pTEX5500ts.
Similarly, a 1,031-bp DNA fragment designated AcmDn (Fig.
2), encompassing some of the coding region of the 3 end of
acm and the downstream region, was amplified from the same
genomic DNA template using primers AcmDelF4 and Acm-
DelR4 (Table 4). The AcmDn PCR product digested with
PstI and SmaI was ligated to similarly digested pTEX5500ts::
AcmUp. This in vitro-ligated construct for generating an acm
deletion (designated pTEX6050 [Fig. 2]) was transformed into
E. coli to obtain TX6050 and was then introduced into elec-
trocompetent cells of TX0082 which were allowed to recover at
room temperature for 2 h; the latter step was found to be
essential for transformation of plasmids into poorly transform-
able strains. The cells were then plated on gentamicin plates at
the permissive temperature (28°C) to select for transformants.
After overnight growth at elevated temperature (42°C), the
cells were plated on chloramphenicol plates and incubated at
37°C. The single-crossover integration (TX0082::pTEX6050)
was tested by PCR (primers sets AcmUp11 and CmR as well as
AcmDownR11 and CmF were used for verifying integration
into AcmUp and AcmDn regions, respectively [Table 4]),
which confirmed that integration was specific and occurred
either in AcmUp or in AcmDn regions in different colonies.
Also, 40 of 40 gentamicin-resistant colonies tested showed
integration. However, PFGE followed by Southern blot prob-
ing showed persistence of free plasmid, in addition to single-
crossover integration, after overnight growth at 42°C. One of
the integrants was picked and was grown for eight serial pas-
sages at a culture temperature of 42°C to completely cure the
plasmid. The cultures from the fifth passage onward were se-
rially diluted and plated at 37°C on nonselective media to
select for plasmid excision by double-crossover recombination.
These master plates were then replica plated to chloramphen-
icol plates and gentamicin plates to identify colonies that re-
tained the cat gene and not the vector. Double crossovers were
expected to be chloramphenicol resistant and gentamicin sen-
sitive, as shown in Fig. 2. We found 4 of 5,000 colonies in
which the acm gene replacement had occurred from the plates
from the eighth passage. One of these colonies was designated
TX6051 (TX0082acm). The deletion was indicated by PCR
with primers AcmUpF11 and AcmDownR11, and the strain’s
identity was confirmed by PFGE (Fig. 3A). Sequencing of this
PCR product confirmed the correct deletion of acm from 38
to 1677 (including the ribosome-binding site, signal se-
quence, complete A domain [binding domain], and 13 amino
acids of the B domain) and is replaced by cat (Fig. 3B). South-
ern hybridizations using the deleted fragment of acm (ampli-
fied from TX0082 using primers AcmF2 and AcmR1 [Table
4]), the cat gene (amplified from pTEX5500ts using primers
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FIG. 2. Protocol used for replacing the acm wild-type sequence on the TX0082 chromosome with the cat gene. The gene replacement construct
(pTEX6050) carrying in vitro-altered sequences (AcmUp, the region upstream of acm [shown by the cross-hatched box], and AcmDn, part of the
acm 3 region as well as the downstream region [shown by the dotted box]) was transformed into E. coli. At permissive temperature (28°C),
pTEX6050 was introduced into TX0082 by electroporation. Colonies were screened for an integration event when the temperature was shifted to
42°C. One of the integrants was grown for eight serial overnight passages at 42°C to completely cure the plasmid. The culture from the eighth
passage was serially diluted and plated at 37°C on nonselective media to select for double crossover recombination. Upon replica plating to
chloramphenicol plates and gentamicin plates, the colonies that retained the cat gene only were identified. One of these colonies was designated
TX6051 (TX0082acm). The gray box represents the cat gene coding for chloramphenicol resistance, and the striped box represents the aph(2)-Id
gene coding for gentamicin resistance.
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5500-MCS-IF and 5500-MCS-IIR [Table 4]), and pTEX5500ts
as probes confirmed the absence of unintegrated plasmid (Fig.
3C and D). Since in silico analysis as well as mRNA analysis of
the acm locus (data not shown) confirmed the monocistronic
nature of acm (and thus predicts absence of a polar effect with
this system), we used a replacement strategy in this study to
introduce the cat marker into the mutant to take advantage of
the discriminatory capability; this will facilitate distinguishing
between wild-type and mutant bacteria after in vivo animal
experiments with mixed cultures.
Characterization of the acm mutant. (i) Growth character-
istics. TX6051 (TX0082acm) colonies appeared smaller in
size compared to the wild type (TX0082) when grown over-
night either on BHI or TH agar. However, no abnormality in
cell shape was noticed when the acm mutant was observed by
light microscopy at various time points of growth. To further
characterize the behavior of the acm mutant, growth was mon-
itored by CFU and OD600. As shown in Fig. 4A, the doubling
time of the acm mutant (TX6051) was longer than that of the
wild type (TX0082) in the lag and early log phases. Also, the
final culture density of the acm mutant in BHI was reproduc-
ibly two times lower than that of the wild type. The growth of
a single-crossover construct (TX0082AcmUp::pTEX6050),
which does not cause an interruption of acm, was similar to the
wild type (Fig. 4A), suggesting that the presence of cat had no
effect on the observed slow growth of acm mutant. Similar
observations were made when growth was monitored by
OD600. Southern hybridization results showed localization of a
single copy of the cat gene to the acm locus without evidence
of a second integration elsewhere in the genome of TX6051
(Fig. 3D).
(ii) Lack of Acm in surface preparations of TX6051 and lack
of adherence of this acm mutant to collagen(s). Western blots
of cell wall-associated proteins released by mutanolysin were
probed with anti-Acm polyclonal antibodies, which we previ-
ously raised against the A domain of Acm (37). A single im-
munoreactive protein of 86 kDa was detected in an endocar-
ditis isolate TX2535 (37) and in TX0082 but not in TX6051
(Fig. 4B). Probing of mutanolysin extracts of these isolates with
preimmune rabbit serum showed no reactive bands in all three
isolates (data not shown).
E. faecium TX0082 and its isogenic acm strain TX6051
were tested for their ability to adhere to immobilized collagen
types I and IV, fibrinogen, and BSA. Strain TX0082 adhered to
collagen(s) and fibrinogen, whereas the acm mutant (TX6051)
was completely defective in adhering to collagen types I and IV
but not to fibrinogen (Fig. 4C). This genetic evidence corrob-
orates our earlier paper indicating that Acm mediated collagen
adherence of E. faecium based on results with recombinant
Acm and complementation of acm-pseudogene containing E.
faecium isolates (37). Using this acm deletion mutant, the role
of acm in E. faecium pathogenesis will be tested in animal
models including endocarditis.
Use of a mobilizable derivative of pTEX5500ts to interrupt
the acm gene of a nonelectroporable E. faecium strain. A mo-
bilizable derivative of pTEX5500ts, designated pTEX5501ts
FIG. 3. Confirmation of allelic replacement of the acm gene of TX6051. (A) PFGE analysis of SmaI-digested genomic DNA of TX0082 (lane
1), four double-crossover colonies that retained the chloramphenicol resistance (lanes 2 to 5), a colony resulting from a single-crossover integration
event (TX0082AcmUp::pTEX6050) (lane 6), and a molecular weight marker (lane 7). Two fragments marked with straight arrows in lane 6 are
due to a SmaI site in the inserted plasmid. The extrachromosomal (nonintegrated) plasmid band is marked with a bent arrow. (B) Illustration of
a 4,474-bp acm region of E. faecium TX6051 (TX0082acm). Sequencing confirmed that 1,663 bp of the acm locus is replaced with a 971-bp cat
cassette. The 5 and 3 regions that were used for recombination events are shown by cross-striped boxes. (C and D) Southern blot analysis of the
digests shown in lanes 1 to 6 of panel A. Panel C was probed with the deleted fragment of acm, and panel D was probed with the cat gene.
Hybridization results obtained with pTEX5500ts are identical to those obtained with its cat gene, as shown in panel D.
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was created by adding oriT from Tn916 in order to transfer it
by conjugation from E. faecalis JH2Sm::Tn916 (6). To generate
the plasmid for insertional inactivation, an 846-bp DNA frag-
ment designated AcmIns, which is an intragenic region of acm,
was amplified from TX2555 genomic DNA template using
primers AcmInsF and Acm19R. The AcmIns PCR product was
digested with BamHI and KpnI and ligated to a similarly di-
gested 5.24-kb BamHI and KpnI gel-eluted fragment from
pTEX5501ts, yielding pTEX6052 (pTEX5501ts::acm). This
plasmid was electroporated into E. coli DH5	 to obtain
TX6052, and from there it was introduced into JH2Sm::Tn916
by electroporation, selecting for gentamicin resistance after
growth at 28°C; a resulting colony was chosen and designated
TX6053. Using the principle of trans-activation (Tn916 pres-
ence in the donor strain activates conjugal transfer of coresi-
dent plasmids carrying oriTTn916 [1, 22]), pTEX6052 from E.
faecalis JH2Sm::Tn916 was mobilized to the nonelectroporable
(in our hands) E. faecium strain TX2555 by broth mating.
Transconjugants were selected for resistance to 125 
g/ml gen-
tamicin and 200 
g/ml erythromycin (present in the recipient).
PFGE analysis confirmed the strain identity of the transcon-
jugant (data not shown). Selected gentamicin-resistant colo-
nies were shown to stably maintain pTEX6052 after growth at
28°C. Subsequently, a culture of TX2555(pTEX6052) was
shifted to 42°C (to cause plasmid loss), grown for 10 serial
passages, serially diluted, and plated on gentamicin at 37°C.
PFGE analysis followed by probing of Southern blots showed
complete loss of detectable plasmid in some colonies (data not
shown). This insertional mutant strain of acm was designated
TX6054.
Growth patterns and adherence characteristics of wild-type
TX2555 versus TX6054 (data not shown) were essentially the
same as we observed with wild-type TX0082 versus TX6051.
We also showed the stability of the acm insertion of TX6054,
without evidence of excised plasmid DNA by Southern blots
using pTEX6052 as a probe, after two overnight in vitro pas-
sages at 37°C and without antibiotic (data not shown). Our
ability to disrupt the acm gene in a nontransformable E. fae-
cium strain using mobilization and recombination events indi-
cate that the same technique could be used for allelic replace-
ment, as described above with pTEX5500ts and TX0082.
Conjugal transfer of a pTEX5501ts-derived plasmid from E.
faecalis JH2Sm::Tn916 to diverse E. faecium clinical strains.
By broth mating, the transfer of pTEX6052 (pTEX5501ts::acm
intragenic fragment) was successful only with the recipient
strain TX2555 (1  108), and no transconjugants were seen
FIG. 4. Characterization of TX6051. (A) Growth curve of wild-type E. faecium strain TX0082, its isogenic acm deletion mutant (TX6051), and
a colony resulting from a single-crossover integration event (TX0082AcmUp::pTEX6050). Aliquots of culture were withdrawn every hour through
the growth cycle for the measurement of CFU. (B) Western blots of mutanolysis extracts of E. faecium isolates (lane 1, TX2535; lane 2, TX0082;
and lane 3, TX6051). Samples were probed with polyclonal antiserum raised against recombinant AcmA (37). (C) Adherence of wild-type E.
faecium TX0082 and its isogenic acm deletion mutant (TX6051) to immobilized collagen types I and IV, fibrinogen, and BSA. Adherence was
tested in wells coated with 1 
g of extracellular matrix (ECM) proteins. Bars represent the mean percentages of cells bound  standard deviations
for eight wells. Results are from four independent experiments. BSA was used as a negative control.
TABLE 5. Transferability of plasmid pTEX6052 (a pTEX5501ts derivative) from E. faecalis JH2Sm::Tn916 to diverse E. faecium clinical
strains by trans-activation
Recipient (source of isolation, place of origin) Antibiotic selection (
g/ml) Transfer frequencye
TX2442 (blood, Belgium)a Gen, 125; Ery, 200 3  109
TX2535 (endocarditis, Houston, Tex.)b,c,d Gen, 125; Ery, 200 3.8  107
TX2067 (clinical isolate, Boston, Mass.)c Gen, 125; Ery, 200 2.0  107
TX2492 (blood, Houston, Tex.)b,c,d Gen, 125; Ery, 200 3.6  108
a Vancomycin resistant, VanA type.
b Vancomycin resistant, VanB type.
c Ampicillin resistant.
d Isolates TX2535 and TX2492 were from different hospitals.
e Transfer frequencies are expressed as number of transconjugants per donor CFU.
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with TX2535 and TX2466. Subsequent experiments with filter
matings demonstrated the transferability of pTEX6052 into
diverse E. faecium clinical strains of different PFGE types, and
the transfer frequencies varied with different strains (Table 5).
From every mating, randomly selected transconjugants were
analyzed for plasmid content and the strain identity was con-
firmed by PFGE (data not shown). These results suggest that
mobilization from an E. faecalis donor is a convenient method
for introducing pTEX5501ts derivatives into diverse clinical
strains of E. faecium and even into the strains that have been
recalcitrant to standard electroporation.
Replication of pTEX5500ts in E. faecalis. To assess the func-
tionality of this plasmid in E. faecalis mutagenesis, transforma-
tion and stability of pTEX5500ts was also tested with E. fae-
calis OG1RF. This plasmid was transformed with better
efficiency (420 CFU/
g of plasmid) into E. faecalis OG1RF
than E. faecium. The permissive temperature as well as plas-
mid loss rates were similar to what we noted for E. faecium.
Since pWV01-based repAts has been used for allelic replace-
ment of several gram-positive bacteria, including lactococci
(3), streptococci (41), staphylococci (17, 54), and Desulfitobac-
terium (53), these new vectors should be applicable for mu-
tagenesis of a broad range of hosts.
In summary, to overcome the limitation of poor transform-
ability of clinical E. faecium isolates, a ts replicon derived from
the low-copy-number plasmid pWV01 was used to construct a
thermosensitive vector which is functional in E. faecium at
permissive temperature and suicidal at nonpermissive temper-
ature. Using this vector, the acm gene of an endocarditis-
derived E. faecium strain was successfully deleted, and this is
the first example to our knowledge of allelic replacement in
this species. More importantly, the transferability of mobiliz-
able derivatives of this vector was demonstrated with nonelec-
troporable E. faecium clinical strains. These vectors will be
particularly useful for genes that do not confer easily screen-
able phenotypes. The improved cloning vector properties of
this system should also be helpful for mutagenesis of other
gram-positive bacteria as well.
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